CLPT
ClearPoint Neuro, Inc.
NASDAQ · USHealthcareMedical - Devices
$15.05-0.66%
Price as of Jul 20, 2026
CLPT financials
ClearPoint Neuro, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $37.0M | $31.4M | $24.0M | $20.6M |
| Cost of revenue | $14.3M | $12.3M | $10.3M | $7.0M |
| Gross profit | $22.7M | $19.1M | $13.6M | $13.5M |
| Operating expenses | $46.9M | $38.9M | $36.1M | $29.9M |
| Operating income | -$24.2M | -$19.7M | -$22.4M | -$16.3M |
| Net income | -$25.5M | -$18.9M | -$22.1M | -$16.4M |
| EBITDA | -$20.9M | -$17.0M | -$20.6M | -$15.6M |
| Basic EPS | $-0.90 | $-0.70 | $-0.90 | $-0.68 |
| Diluted EPS | $-0.90 | $-0.70 | $-0.90 | $-0.68 |
| Balance sheet | ||||
| Cash & equivalents | $45.9M | $20.1M | $23.1M | $27.6M |
| Total assets | $97.7M | $39.2M | $42.7M | $55.5M |
| Total liabilities | $69.7M | $13.8M | $21.5M | $18.6M |
| Stockholders’ equity | $28.0M | $25.4M | $21.2M | $36.9M |
| Total debt | $58.2M | $3.6M | $13.9M | $12.0M |
| Net debt | $12.3M | -$16.5M | -$9.2M | -$15.6M |
| Cash flow | ||||
| Operating cash flow | -$23.9M | -$8.9M | -$13.7M | -$16.2M |
| Capital expenditure | -$522.0K | -$275.0K | -$717.0K | -$253.0K |
| Free cash flow | -$24.4M | -$9.2M | -$14.4M | -$16.4M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | -$210.0K | $0.00 |